Life Tech CEO Says Renewed Licensing Effort, Digital PCR Patents Will Spur Royalties

A new licensing team at Life Technologies helped reduce the decline in 2009 PCR patent royalties to around $20 million instead of $30 million, and it appears that 2010 will see no deterioration at all.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.